Allarity Therapeutics Profit Margin

Allarity Therapeutics (ALLR) currently reports a profit margin of -5.22% as of March 2026. That is below the sector sector average of 19.74%. Use the charts on this page to explore Allarity Therapeutics's profit margin history and peer comparisons.

Allarity Therapeutics's profit margin of -5.22% is lower than the its sector sector average of 19.74%. That is roughly 126.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Allarity Therapeutics's current -5.22% should be judged against industry norms (sector average: 19.74%) and against ALLR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -5.22%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.74%. From there, open related valuation or income-statement pages for Allarity Therapeutics, and consider following ALLR for alerts when major investors trade the stock.